Lail A Kleinman

Array ( [id] => 6769510 [patent_doc_number] => 20030215450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders' [patent_app_type] => new [patent_app_number] => 10/276939 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14198 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215450.pdf [firstpage_image] =>[orig_patent_app_number] => 10276939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787187 [patent_doc_number] => 20030138426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Human tumor necrosis factor receptor-like proteins TR11, TR11SV1, and TR11SV2' [patent_app_type] => new [patent_app_number] => 10/283105 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 124568 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138426.pdf [firstpage_image] =>[orig_patent_app_number] => 10283105 [rel_patent_id] =>[rel_patent_doc_number] =>)